Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$6.87 USD
+0.22 (3.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.85 -0.02 (-0.29%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.48 |
Last EPS Surprise | -2.13% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.59 |
Next Year | -0.63 |
EPS (TTM) | -1.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.70M | 5.05M | 24.97M | 78.35M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 2.99M | 5.39M | 27.94M | 95.00M |
Low Estimate | 2.40M | 4.70M | 23.26M | 59.86M |
Year ago Sales | 0.04M | 0.18M | 5.12M | 24.97M |
Year over Year Growth Est. | 6,637.50% | 2,702.78% | 387.24% | 213.83% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.47 | -1.59 | -0.63 |
# of Estimates | 2 | 2 | 4 | 3 |
Most Recent Consensus | -0.48 | -0.40 | -1.39 | -0.60 |
High Estimate | -0.48 | -0.40 | -1.39 | -0.55 |
Low Estimate | -0.59 | -0.53 | -2.02 | -0.75 |
Year ago EPS | -0.13 | -0.21 | -1.14 | -1.59 |
Year over Year Growth Est. | -315.38% | -123.81% | -39.47% | 59.85% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 4 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.47 | -1.59 | -0.63 |
7 Days Ago | -0.54 | -0.47 | -1.59 | -0.63 |
30 Days Ago | -0.54 | -0.47 | -1.59 | -0.63 |
60 Days Ago | -0.58 | -0.52 | -1.36 | -0.63 |
90 Days Ago | -0.58 | -0.52 | -1.36 | -0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.47 | -1.59 | -0.63 |
Zacks Consensus Estimate | -0.54 | -0.47 | -1.59 | -0.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.48 | -0.32 | -0.21 | -0.13 | NA |
Estimate | -0.47 | -0.22 | -0.22 | -0.20 | NA |
Difference | -0.01 | -0.10 | 0.01 | 0.07 | -0.01 |
Surprise | -2.13% | -45.45% | 4.55% | 35.00% | -2.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more